Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Ferrous Sulfate 200mg Coated Tablets
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Ferrous sulfate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
What you need to know before you take it
e and itching caused by liver disease Ferrous Sulfate Tablets
- dimercaprol used to treat metal poisoning
- methyldopa used to treat high blood pressure Do not take Ferrous Sulfate Tablets if you:
- mycophenolate mofetil, used to suppress the
- are allergic to ferrous sulfate or any of the other immune system stop organ rejection after transplant ingredients of this medicine (listed in section 6)
- penicillamine used to treat rheumatic diseases
- have an ulcer of your stomach or small intestine
- trientine used in Wilson's disease, a disorder where
- suffer from iron storage diseases, where the body the body stores too much copper contains more iron than it should
- zinc supplements.
- have had repeated blood transfusions
- suffer from haemolytic anaemia (anaemia due to the Warnings and precautions destruction of red blood cells) Due to the risk of mouth ulceration and tooth
- have anaemia caused by a deficiency of vitamin discolouration, tablets should not be sucked, chewed B12 or folic acid or kept in the mouth but swallowed whole with water.
- are already being treated with iron supplements If you cannot follow this instruction or have difficulty
- suffer from rare intolerances to sugar. swallowing, please contact your doctor. Talk to your doctor or pharmacist before taking Ferrous Sulfate tablets with food and drink Ferrous Sulfate Tablets if you: Do not take this medicine with tea, milk or eggs as
- have had a gastrectomy (operation to remove all or they reduce the absorption of it in the stomach. part of your stomach) Pregnancy and breast-feeding
- have a history of stomach ulcers During the first 12 weeks of pregnancy only take this
- suffer from diabetes medicine if your doctor has specifically recommended
- suffer from inflammatory bowel disease it. For the remainder of the pregnancy Ferrous Sulfate
- suffer from diverticular disease (where pouches form Tablets can be taken to prevent iron deficiency. in the bowel wall) Driving and using machines
- have intestinal strictures (abnormal narrowing of the This medicine does not affect your ability to drive a bowel caused by inflammation). car or operate machinery. Other medicines and Ferrous Sulfate Tablets Ferrous Sulfate Tablets contains sodium, sucrose Tell your doctor or pharmacist if you are taking, have and glucose recently taken or might take any other medicines, This medicine contains less than 1 mmol sodium including any medicines obtained without a (23mg) per tablet, that is to say it is essentially prescription. 'sodium-free'. The following medicines can affect or be affected by This medicine contains sucrose and glucose. If treatment with Ferrous Sulfate Tablets: you have been told by your doctor that you have
- medicines used to treat indigestion (antacids and an intolerance to some sugars, contact your doctor mineral supplements e.g. calcium, magnesium, before taking this medicinal product.
Customer
Wockhardt UK Limited
Description
Ferrous sulfate leaflet
Item Code
104564/8
Profile
as supplied
Size
140 x 210mm
Min.Point Size
Other
Market
UK
Language
English
FPO
Pharma Height
7mm Minimum
PRINTING COLOURS Black
DATE
Warning! We cannot accept responsibility for any errors in this proof after approval. Whilst we take extreme care at all times to ensure accuracy to our client's brief, the final responsibility must be taken by our client. IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING FULL APPROVAL OF DESIGN AND TEXT.
Barcode Proof By
HGA
Proof No.
3
Date
23.12.2025
Body Text Fonts: Arial
Keyline (Non-Printing) Technical Info (Non-Printing)
16 East Park Road | Leicester | LE5 4QA | UK
APPROVAL SIGNATURE
TECHNICAL COLOURS
Actual Min Point Size 7 pt
How to take it
Ferrous Sulfate Tablets Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor or pharmacist if you are not sure. Swallow the tablet whole with water. Do not suck, chew or keep the tablet in your mouth. Adults and the elderly Prevention of Iron-deficiency Anaemia
- One tablet per day. Children and adolescents
- Ferrous Sulfate Tablets are not recommended for use in children and adolescents. Treatment of Iron-deficiency Anaemia
- One tablet two or three times per day. Treatment should not last more than three months after anaemia is controlled. If you take more Ferrous Sulfate Tablets than you should If you (or anybody else, especially a child) takes more Ferrous Sulfate Tablets than you should contact your nearest hospital casualty department or doctor immediately. Always take the container of tablets and this leaflet with you. If you forget to take Ferrous Sulfate Tablets If you forget a dose, take another one as soon as you remember. If it is almost time for your next dose, then do not take the missed dose at all. Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. As can happen with any medicine, a few people may develop an allergic reaction. If you experience any of the following, seek medical help immediately;
- rash, itching, or difficulty breathing. Side effects that have been reported are:
- stomach pains
- constipation
- dark stools
- feeling or being sick
- diarrhoea. Not known (frequency cannot be estimated from the available data) Mouth ulceration (in case of incorrect use, when tablets are chewed, sucked or left in the mouth). Elderly patients and patients with difficulty swallowing may also be at risk of ulceration of the throat, oesophagus (the tube that connects your mouth with your stomach) or bronchus (the major air passages of the lungs) if the tablet enters the airways. Irritation and ulceration of the gullet can occur if the tablets become stuck so take with water. If you take this medicine for longer than you should you are at an increased risk of tooth decay and infections. If you experience any side effects or feel that the medicine is affecting you badly tell your doctor or pharmacist immediately.
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible
Possible side effects
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
How to store it
Ferrous Sulfate Tablets Keep out of the sight and reach of children.
- Ferrous Sulfate Tablets should not be stored above 25°C. Store in the original container to protect from moisture.
- Ferrous Sulfate Tablets should not be taken after the expiry date on the label; the expiry date refers to the last day of the month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Contents of the pack and other information
What Ferrous Sulfate Tablets contain The active ingredient is ferrous sulfate 200mg equivalent to 65mg of ferrous iron Fe(II). The other ingredients are: kaolin, glucose, povidone, stearic acid, magnesium stearate, sodium lauryl sulfate, starch, opaglos, titanium dioxide (E171), sucrose and talc (E553B). What Ferrous Sulfate Tablets look like and the contents of pack Ferrous Sulfate Tablets are white, sugar coated tablets. The medicine is supplied in packs of 50, 100, 250, 500, and 1000 tablets contained in a screw cap plastic containers or blister packs of 28 tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder: Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, UK Manufacturer: CP Pharmaceuticals Ltd, Ash Road North, Wrexham, LL13 9UF, UK Other formats: To listen to or request a copy of this leaflet in Braille, large print or audio please call free of charge 0800 198 5000 (UK only) Please be ready to give the following information: Product name
Reference number
Ferrous Sulfate 200mg Coated Tablets
29831/0220
This service is provided by the Royal National Institute of Blind people. This leaflet was last revised in 11/2025.
104564/8
Customer
Wockhardt UK Limited
Description
Ferrous sulfate leaflet
Item Code
104564/8
Profile
as supplied
Size
140 x 210mm
Min.Point Size
Other
Market
UK
Language
English
FPO
Pharma Height
7mm Minimum
PRINTING COLOURS Black
DATE
Warning! We cannot accept responsibility for any errors in this proof after approval. Whilst we take extreme care at all times to ensure accuracy to our client's brief, the final responsibility must be taken by our client. IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING FULL APPROVAL OF DESIGN AND TEXT.
Barcode Proof By
HGA
Proof No.
3
Date
23.12.2025
Body Text Fonts: Arial
Keyline (Non-Printing) Technical Info (Non-Printing)
16 East Park Road | Leicester | LE5 4QA | UK
APPROVAL SIGNATURE
TECHNICAL COLOURS
Actual Min Point Size 7 pt
Frequently asked questions about Ferrous Sulfate 200mg Coated Tablets
How do I take Ferrous Sulfate 200mg Coated Tablets?
Ferrous Sulfate 200mg Coated Tablets comes as tablet containing 200mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Ferrous Sulfate 200mg Coated Tablets?
The active substance in Ferrous Sulfate 200mg Coated Tablets is ferrous sulfate.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Ferrous Sulfate 200mg Coated Tablets, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Ferrous Sulfate 200mg Coated Tablets without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: ferrous sulfate
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
Ferrous Sulfate is used for iron-deficiency anaemia.
4.2. Posology and method of administration
For iron-deficiency anaemia:-
Adults:-
Prophylaxis - One tablet daily
Therapeutic - One tablet 2-3 times daily
Elderly:-
As for adults
Children:-
This presentation is not recommended.
Method of administration:
The tablets should not be sucked, chewed or kept in the mouth, but swallowed whole with water.
Tablets should be taken before meals or during meals, depending on gastrointestinal tolerance.
4.3. Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1; haemosiderosis and haemochromatosis; active peptic ulcer; repeated blood transfusion; haemolytic anaemia. Oral and parenteral iron preparations should not be used concomitantly.
4.4. Special warnings and precautions for use
Patients post-gastrectomy have poor absorption of iron. Caution is advised when prescribing iron preparations to individuals with history of peptic ulcer, and inflammatory bowel disease, including regional enteritis and ulcerative colitis. Care should be taken in patients with intestinal strictures or diverticulae. Duration of treatment should generally not exceed 3 months after correction of anaemia. Co-existing deficiency of vitamin B12 or folic acid should be ruled out since combined deficiency produces microcytic blood film. Dental caries is a definite risk following long term treatment with this product. These tablets contain sugar and should be administered with care to patients with diabetes. Patients suffering from iron overload are particularly susceptible to infection. Treatment of iron overload should be with caution.
Due to the risk of mouth ulcerations and tooth discolouration, tablets should not be sucked, chewed or kept in the mouth, but swallowed whole with water.
The label will state:
“Important warning: Contains iron. Keep out of the sight and reach of children, as overdose may be fatal.”
This will appear on the front of the pack within a rectangle in which there is no other information.
Patients with rare hereditary problems of fructose intolerance, glucose- galactose malabsorption or sucrase- isomaltase insufficiency should not take this medicine.
This medicine contains less than 1mmol sodium (23mg) per tablet, that is to say essentially 'sodium-free'.
4.5. Interaction with other medicinal products and other forms of interaction
Antacids and mineral supplements: Compounds containing calcium, magnesium (including antacids and mineral supplements), bicarbonates, carbonates, oxalates or phosphates may impair the absorption of iron. Administration of iron preparations with such compounds should be separated by at least 2 hours.
Antibacterials: Iron and tetracyclines reduce the absorption of each other when administered concomitantly. Administration of iron preparations and tetracyclines should be separated by 2 to 3 hours. Iron may reduce the absorption of quinolones. Administration of iron preparations and quinolones should be separated by at least 2 hours. Chloramphenicol delays plasma clearance of iron, incorporation into red blood cells by interfering with erythropoiesis.
Biphosphonates: The absorption of biphosphonates is reduced when taken concurrently with iron preparations. Administration should be separated by at least 2 hours.
Cholestyramine: Absorption of iron is impaired by cholestyramine.
Dimercaprol: Concomitant administration of oral iron preparations and dimercaprol should be avoided.
Dopaminergics: Oral iron preparations may reduce the absorption of dopaminergics such as co-careldopa, entacapone and levodopa.
Food Products: Absorption of iron is impaired by tea, eggs or milk.
Methyldopa: Oral iron preparations may antagonise the antihypertensive effect of methyldopa.
Mycophenolate mofetil: Oral iron preparations significantly reduce the absorption of mycophenolate mofetil.
Penicillamine: Oral iron preparations can reduce the absorption of penicillamine. Also the absorption of iron is impaired by penicillamine.
Thyroid hormone: Ferrous sulfate reduces the absorption of levothyroxine and so should be taken at least 2 hours apart.
Trientine: the absorption of oral iron preparations is reduced by trientine. Administration should be separated by at least 2 hours.
Zinc: iron preparations and zinc preparations can reduce the absorption of each other.
4.6. Pregnancy and lactation
Use of any drug during the first trimester of pregnancy should be avoided if possible. Thus administration of iron during the first trimester requires definite evidence of iron deficiency.
Prophylaxis of iron deficiency during the remainder of pregnancy is justified.
4.7. Effects on ability to drive and use machines
None known.
4.8. Undesirable effects
Gastro-intestinal disorders: abdominal pain, nausea and vomiting (these are usually dose related), constipation, diarrhoea and dark stools. Contact irritation can occur with ferrous sulfate tablets resulting in erosion or ulceration, particularly if they become lodged in the upper gastrointestinal tract.
Allergic reactions have been reported.
Post-marketing: The following ADRs have been reported during post-marketing surveillance. The frequency of these reactions is considered not known (cannot be estimated from the available data).
Gastrointestinal disorders:
mouth ulceration*
* in the context of incorrect administration, when the tablets are chewed, sucked or kept in mouth. Elderly patients and patients with deglutition disorders may also be at risk of oesophageal lesions or of bronchial necrosis, in case of false route.
Reporting of suspected adverse reactions
Reporting suspected adverse drug reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
Acute iron overdosage can be divided into four stages. In the first phase, which occurs up to 6 hours after oral ingestion, gastrointestinal toxicity, notably vomiting and diarrhoea, predominates. Other effects may include cardiovascular disorders such as hypotension and tachycardia, metabolic changes including acidosis and hyperglycaemia, and CNS depression ranging from lethargy to coma. Patients with only mild to moderate poisoning do not generally pass this first phase. The second phase may occur at 6-24 hours after ingestion and is characterised by a temporary remission or clinical stabilisation. In the third phase gastrointestinal toxicity recurs together with shock, metabolic acidosis, convulsions, coma, hepatic necrosis and jaundice, hypoglycaemia, coagulation disorders, oliguria or renal failure, and pulmonary oedema. The fourth phase may occur several weeks after ingestion and is characterised by gastrointestinal obstruction and possibly late hepatic damage.
Overdosage of ferrous salts is particularly dangerous to young children.
Treatment consists of gastric lavage followed by the introduction of 5g desferrioxamine into the stomach. Serum iron levels should be monitored and in severe cases iv desferrioxamine should be given together with supportive and symptomatic measures as required. Gastric lavage with 5% sodium bicarbonate and saline cathartics (e.g. sodium sulfate 30g for adults); milk and eggs with 5g bismuth carbonate every hour as demulcents. Blood or plasma transfusion for shock, oxygen for respiratory embarrassment. Chelating agents (e.g. disodium calcium edetate) may be tried (500mg/500ml by continuous iv infusion). Dimercaprol should not be used since it forms a toxic complex with iron. Desferrioxamine is a specific iron chelating agent and severe acute poisoning in infants should always be treated with desferrioxamine at a dose of 90mg/kg im followed by 15mg/kg per hour iv until the serum iron is within the plasma binding capacity.
💬 Ask about this leaflet
Ask anything about Ferrous Sulfate 200mg Coated Tablets. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.